We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 94

Coming soon to Canadian medical device manufacturers? "Failure to train" cases south of the border
  • Gowling WLG
  • USA, Canada
  • October 21 2014

Medical device manufacturers (“MDMs”) often have to defend against novel theories of liability put forward by plaintiff counsel. The most recent


PMPRB asserts jurisdiction over US-based sales
  • Gowling WLG
  • USA, Canada
  • February 7 2008

In a recent decision, the Patented Medicine Prices Review Board (PMPRB) has ruled that it has jurisdiction over products sold in the U.S., but imported into Canada under Health Canada's Special Access Program (SAP).


QLT Inc. up for sale
  • Gowling WLG
  • USA, Canada
  • December 6 2007

On November 27, 2007, Vancouver-based QLT Inc. announced that it has formed a special committee of directors to "review the company's strategic alternatives", which typically means that a company has put itself up for sale.


Peter Simeon
  • Gowling WLG

Isabel Raasch
  • Gowling WLG



Josh Rosen
  • Gowling WLG

Some Canadian biotech companies unhappy with length of FDA approval process
  • Gowling WLG
  • USA, Canada
  • May 29 2008

Canadian biotech companies amongst other countries' companies are reported recently to have been indicating their unhappiness with the speed with which the FDA is approving new drugs.


Scott E. Foster
  • Gowling WLG